XIT Corp formerly GSR III Acquisition Corp is a United States-based company. The Company is a wholly owned subsidiary of Terra Innovatum Global N.V. The Company is not engaged in any business activities. The Company has no revenue.

Employees

Sector

Investment Holding Companies

More about the company

Quotes

Date	Price	Change	Volume
21/26/21	$4.130	+3.77%	5,04,982
18/26/18	$3.980	-5.24%	43,63,592
17/26/17	$4.200	+0.60%	10,43,302
16/26/16	$4.175	-9.04%	7,01,383
15/26/15	$4.590	-2.75%	3,47,379

Delayed Quote Nasdaq

More quotes

Market Closed - Nasdaq 01:30:00 22/09/2026 am IST			5-day change	1st Jan Change
4.130 ^USD	+3.77%		-12.50%	-73.39%

17/11	GSR III Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
10/25/10	Terra Innovatum Global Completes Business Combination With GSR III Acquisition	MT

Market Cap	45Cr 39Cr 37Cr 34Cr 63Cr 4.34TCr 64Cr 445.27Cr 171.62Cr 2.21TCr 170.07Cr 166.3Cr 7.13TCr	P/E 2023 *	-	P/E 2024	95.2x
Enterprise Value	45Cr 39Cr 37Cr 34Cr 63Cr 4.32TCr 63Cr 443.51Cr 170.94Cr 2.2TCr 169.4Cr 165.65Cr 7.1TCr	EV / Sales 2023 *	-	EV / Sales 2024	-
Free-Float	16.3%	Yield 2023 *	-	Yield 2024	-

17/11	GSR III Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
10/25/10	Terra Innovatum Global Completes Business Combination With GSR III Acquisition	MT
10/25/10	Terra Innovatum to begin trading on Nasdaq under the symbol "NKLR"	RE
09/25/09	GSR III Acquisition Corp.(NasdaqGM:GSRT) dropped from NASDAQ Composite Index	CI
09/25/09	Terra Innovatum s.r.l. completed the acquisition of GSR III Acquisition Corp. from GSR III Sponsor LLC and others in a reverse merger transaction.	CI
07/25/07	GSR III Acquisition Shareholders Approve Merger With Terra	MT
30/25/30	Terra Innovatum Announces Strategic Alliance with Defense Engineering Center, RAIT 88, to Accelerate Global Commercialization of SOLO?? Micro-Modular Nuclear Reactors	CI
29/25/29	Ameresco Signs MOU With GSR III, Terra Innovatum to Deploy Reactor Units	MT
29/25/29	Terra Innovatum signs MoU with Ameresco	RE
29/25/29	Terra Innovatum Partners with Ameresco to Jointly Pursue Public-Private Commercial Opportunities in the U.S. and Global Markets to Deploy SOLO Micro-Modular Reactor	CI
25/25/25	GSR III Acquisition, Terra Innovatum Secure $37.5 Million Equity Financing for Business Combination	MT
23/25/23	Roth Capital Initiates GSR III Acquisition Corp at Buy	MT
23/25/23	GSR III Acquisition Corp. announced that it expects to receive $31.84 million in funding	CI

23/25/23	Roth Capital Initiates GSR III Acquisition Corp at Buy	MT
12/25/12	Benchmark Initiates GSR III Acquisition at Buy With $19 Price Target	MT

GSR IIIPAR Share Price

Stocks

GSRT

KYG4R1031072

Investment Holding Companies

Valuation: GSR IIIPAR

Chart: GSR IIIPAR

Latest news: GSR IIIPAR

Analysts' recommendations: GSR IIIPAR

Press Releases: GSR IIIPAR

Quotes and Performance

Price Extremes

Latest insider transactions

Shell Companies

Financials

Company Profile

Quotes

30/25/30	Terra Innovatum and GSR III Acquisition Corp. Remind Shareholders to Vote and Approve the Business Combination Prior to the October 7 Extraordinary General Meeting of Shareholders	AQ
22/25/22	Terra Innovatum Advances U.S. NRC Licensing Process with Accelerated Regulatory Submissions for SOLO™ Reactor	AQ
16/25/16	Terra Innovatum Signs Supplier MOU with Conuar for Key SOLO Micro-Modular Reactor Components	AQ
15/25/15	Terra Innovatum and GSR III Acquisition Corp. Announce Effectiveness of S-4 and Set Extraordinary General Meeting Date to Approve Business Combination	AQ
09/25/09	TerraInnovatum Partners with ATB Riva Calzoni for Manufacturing of SOLO Micro-Modular Nuclear Reactor	AQ

1 year	4.09	15.62
3 years	4.09	15.62
5 years	4.09	15.62
10 years	4.09	15.62

Date	Insider	Type	Main position	Quantity	% Market Cap.
16/10/25	Massimo Morichi	Conversion	See remarks; Director	360	4.4776%
16/10/25	Giordano Morichi	Conversion	See remarks	320	3.9801%
16/10/25	Guillaume Moyen	Conversion	Chief Financial Officer; Director	20	0.2488%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
GSR IIIPAR	+3.77%	-12.50%	-61.07%	-	45Cr
CHURCHILL CAPITAL CORP XI	+5.27%	+13.17%	-	-	76Cr
DRUGS MADE IN AMERICA ACQUISITION II CORP.	-0.15%	-0.25%	-	-	65Cr
CENTIEL AG	+1.53%	+16.49%	+311.39%	-72.46%	65Cr
BAIN CAPITAL GSS INVESTMENT CORP.	-0.49%	-0.58%	-	-	60Cr
CHURCHILL CAPITAL CORP XII	+1.93%	+0.65%	-	-	60Cr
CANTOR EQUITY PARTNERS IV, INC.	-0.39%	-0.63%	+1.08%	-	59Cr
AMERICAN EXCEPTIONALISM ACQUISITION CORP. A	+1.17%	+0.36%	-	-	56Cr
CHURCHILL CAPITAL CORP XIII	-5.50%	0.00%	-	-	49Cr
Average	+0.79%	+1.69%	+83.80%	-72.46%	59.32Cr
Weighted average by Cap.	+0.97%	+2.57%	+103.43%	-72.46%

	2023	2024
Net sales	-	-
Net income	-24.75T -21.58T -20.32T -18.51T -34.7T -23.71L -34.74T -2L -93.8T -12.08L -92.96T -90.9T -38.97L	9L 8L 8L 7L 13.31L 9.09Cr 13.33L 93.36L 35.98L 4.63Cr 35.66L 34.87L 15Cr
Net Debt	-	-1.79 -1.56 -1.47 -1.34 -2.51 -171.2 -2.51 -17.57 -6.77 -87.21 -6.71 -6.56 -281.42

1 day	+3.77%
Current month	-73.39%
Current year	-73.39%